Literature DB >> 18763191

Suppression of the production of extracellular matrix and alpha-smooth muscle actin induced by transforming growth factor-beta1 in fibroblasts of the flexor tendon sheath by hepatocyte growth factor.

Dapeng Jiang1, Zhitao Jiang, Zhaozhu Li, Yubo Zhang.   

Abstract

We examined the effectiveness of hepatocyte growth factor (HGF) in blocking production of transforming growth factor (TGF)-beta1-induced collagen I, fibronectin, and alpha-smooth muscle actin (alpha-SMA) in the flexor tendon sheath of rabbits in vitro. Fibroblasts were obtained from the sheaths. Cell culture was supplemented with TGF-beta1 5 ng/ml and increasing doses of HGF (10-40 ng/ml). The production of collagen I and fibronectin in supernatants culture were examined using an enzyme-linked immunosorbent assay (ELISA). alpha-SMA expression was assessed by western blot. TGF-beta1 stimulated production of collagen I, fibronectin, and alpha-SMA greatly, while HGF significantly (p<0.05) reduced production of all components induced by TGF-beta1 in a dose-dependent manner. This suggests that HGF effectively antagonises the action of TGF-beta1 in cultured fibroblasts from flexor tendon sheaths. The results provide a cellular and molecular basis for HGF acting as a therapeutic agent for adhesions in flexor tendons.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18763191     DOI: 10.1080/02844310802045277

Source DB:  PubMed          Journal:  Scand J Plast Reconstr Surg Hand Surg        ISSN: 0284-4311


  2 in total

1.  FAK activity is required for HGF to suppress TGF-β1-induced cellular proliferation.

Authors:  Zheng Zhao; Yu Sun; Sulong Yang; Qingbo Cui; Zhaozhu Li
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-04-22       Impact factor: 2.416

2.  Modulation of wound contracture alpha-smooth muscle actin and multispecific vitronectin receptor integrin alphavbeta3 in the rabbit's experimental model.

Authors:  Cynthia G El Kahi; Bishara S Atiyeh; Inaya Abdallah Hajj Hussein; Rosalyne Jurjus; Saad A Dibo; Alice Jurjus; Abdo Jurjus
Journal:  Int Wound J       Date:  2009-06       Impact factor: 3.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.